Mercedes Meyer
Mercedes K. Meyer, Ph.D., a partner in the Intellectual Property Practice Group, collaborates with her biotechnology and pharmaceutical clients on their patent portfolio strategy. She has an extensive biotechnology and pharmaceutical patent prosecution practice.
She drafts, prosecutes and opines U.S. patents and patent applications, as well as oversees patent portfolio management and development in the U.S. as well as coordinating efforts overseas. She advises on biotechnology-related bioethics issues, such as tissue banking and stem cells. Mercedes also obtains patent term extensions, oversees obtaining Supplemental Protection Certificates (SPCs) and their equivalents abroad and handles requests for reconsideration of patent term adjustment.
She protects clients on such subjects as antibodies, enzymes, especially those useful in the biofuels and industrial enzyme areas, viral vectors, genomics, vaccines, stem cell research, gene therapy, drug screening and identification, protein and tissue arrays, cancer therapeutics, cancer diagnostics, X-ray protein crystallography, beverages, industrial enzymes for biofuels and cosmetics. Her doctoral background provides practical research experience in the area of retroviruses, including HIV-1, virology, molecular biology, cancer biology, immunology and protein chemistry.
Mercedes co-authored Patent Ethics – Prosecution (2009) with David Hricik for Oxford University Press. She speaks and provides expert opinions on ethics issues arising from patent prosecution.
Because of her Washington, D.C., location, Mercedes attends many of the United States Patent & Trademark Office (USPTO) Customer Partnership meetings and reports relevant issues to her clients to assist them in staying abreast of changing policies and procedures at the USPTO.
In General. Mercedes received her bachelor’s degree in chemistry from Bryn Mawr College in 1988 and her Ph.D. in virology from the University of Texas Graduate School of Biomedical Sciences at Houston and The University of Texas M.D. Anderson Cancer Center in 1994. She earned her J.D. from the University of Houston Law Center in 1996. She is admitted to practice in Texas and the District of Columbia and registered to practice before the USPTO.
Mercedes is an active member of the American Intellectual Property Law Association (AIPLA). She is the past chairperson of the Women in IP Law Committee and past vice chairperson of the Biotechnology Committee. Mercedes currently sits on the Board of Directors of AIPLA.
Presentations:
Patent Eligibility Under Attack: Lab Corp., Myriad, Classen & Prometheus: The New World in U.S. Biotech?
Chartered Institute of Patent Attorneys
March 5, 2013
London, England